Condition: Inflammatory Bowel Diseases · Colitis, Ulcerative · Crohn Disease · Sponsor: University of Ulm
Interested? Contact the study team ↓
In the context of the COLORIZE study, it is being tested whether the endoscopic light mode Texture and Color Enhancement Imaging (TXI) is non-inferior to the standard White Light Endoscopy (WLE) in assessing inflammatory activity in patients with Inflammatory Bowel Disease (IBD). For this purpose, ileocolonoscopy is performed on patients diagnosed with IBD, and standardized image documentation will be carried out in both WLE and TXI modes. Step biopsies are taken, and clinically validated, endoscopic, and histological scores are used.
This description comes directly from the study's public registry record.
Benjamin Michael Walter, Prof. Dr. med. · +497315000 · benjamin.walter@uniklinik-ulm.de
Anna Melzer, Dr. med. · anna.melzer@uniklinik-ulm.de
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Histologically confirmed inflammatory bowel disease (ulcerative colitis or Crohn\'s disease) * Age ≥ 18 years Exclusion Criteria: * Post (procto-) colectomy * Endoscopically impassable stenosis in the left hemi-colon * ASA status \> 2 points * BBPS \< 6 points (or \< 2 points per segment) * Severe coagulation disorder * Pregnancy, lactation
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Ulm University Hospital | Ulm, Baden-Wurttemberg, Germany | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.